FDA
approval
· 2025-01-28
FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
Summary
FDA approved a generic fixed-dose combination of triamterene and hydrochlorothiazide from Macleods Pharmaceuticals Limited under an original application.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)